Kawanishi T, Ohno Y, Takahashi A, Takanaka A, Kasuya Y, Omori Y
Biochem Pharmacol. 1985 Apr 1;34(7):919-24. doi: 10.1016/0006-2952(85)90590-8.
Effects of SKF 525A (0.1 mM), metyrapone (0.1 mM), alpha-naphthoflavone (ANF) (0.5 mM) and pyrazole (1.0 mM) on N-nitrosodimethylamine (NDMA), N-nitrosomethylbutylamine (NMBuA) and N-nitrosomethylbenzylamine (NMBeA) metabolism by hepatic microsomes from rats pretreated with inducers were investigated. NDMA demethylation was weakly increased by phenobarbital (PB) treatment. The demethylation was inhibited by SKF 525A and enhanced by metyrapone in non-treated and PB-treated microsomes, and weakly inhibited by ANF in 3-methylcholanthrene(MC)-treated microsomes. NMBuA demethylation was increased by PB treatment and inhibited by SKF 525A in all microsomes. Metyrapone inhibited the demethylation in PB-treated microsomes. NMBuA debutylation was increased by PB and MC treatments, and inhibited by metyrapone in all microsomes. The strongest inhibition by metyrapone was observed in PB-treated microsomes. The debutylation was inhibited by SKF 525A in non-treated and PB-treated microsomes and by ANF in MC-treated microsomes. NMBeA demethylation was decreased by MC treatment and weakly inhibited by SKF 525A in all microsomes. The effects of the inducers and inhibitors on NMBeA debenzylation were almost the same as those on NMBuA debutylation except that the increasing effect of MC was small. Pyrazole was a relatively selective inhibitor of NDMA demethylation. These results suggest the following: NDMA demethylation is catalyzed by PB-induced cytochrome P-450 species (P450-PB) and MC-induced cytochrome P-450 species (P448-MC). But their specific activity is low and the other cytochrome P-450 species demethylate NDMA. NMBuA demethylation is catalyzed by P450-PB. But the specific activity is not high and the other cytochrome P-450 species also demethylate NMBuA. NMBuA debutylation is catalyzed by P450-PB and P448-MC. Almost all of NMBeA demethylation is catalyzed by cytochrome P-450 species other than P450-PB and P448-MC. NMBeA debenzylation is catalyzed by P450-PB and P448-MC, but the specific activity of P448-MC is not high.
研究了SKF 525A(0.1 mM)、甲吡酮(0.1 mM)、α-萘黄酮(ANF)(0.5 mM)和吡唑(1.0 mM)对经诱导剂预处理的大鼠肝微粒体代谢N-亚硝基二甲胺(NDMA)、N-亚硝基甲基丁胺(NMBuA)和N-亚硝基甲基苄胺(NMBeA)的影响。苯巴比妥(PB)处理可使NDMA去甲基化略有增加。在未处理和PB处理的微粒体中,SKF 525A可抑制去甲基化,甲吡酮可增强去甲基化,而在3-甲基胆蒽(MC)处理的微粒体中,ANF可轻微抑制去甲基化。在所有微粒体中,PB处理可增加NMBuA去甲基化,SKF 525A可抑制其去甲基化。甲吡酮可抑制PB处理的微粒体中的去甲基化。PB和MC处理均可增加NMBuA脱丁基化,在所有微粒体中,甲吡酮均可抑制其脱丁基化。在PB处理的微粒体中观察到甲吡酮的抑制作用最强。在未处理和PB处理的微粒体中,SKF 525A可抑制脱丁基化,在MC处理的微粒体中,ANF可抑制脱丁基化。MC处理可降低NMBeA去甲基化,在所有微粒体中,SKF 525A可轻微抑制其去甲基化。诱导剂和抑制剂对NMBeA脱苄基化的影响与对NMBuA脱丁基化的影响几乎相同,只是MC的增加作用较小。吡唑是NDMA去甲基化的相对选择性抑制剂。这些结果表明:NDMA去甲基化由PB诱导的细胞色素P-450种类(P450-PB)和MC诱导的细胞色素P-450种类(P448-MC)催化。但其比活性较低,其他细胞色素P-450种类也可使NDMA去甲基化。NMBuA去甲基化由P450-PB催化。但其比活性不高,其他细胞色素P-450种类也可使NMBuA去甲基化。NMBuA脱丁基化由P450-PB和P448-MC催化。几乎所有的NMBeA去甲基化由P450-PB和P448-MC以外的细胞色素P-450种类催化。NMBeA脱苄基化由P450-PB和P448-MC催化,但P448-MC的比活性不高。